Abstract A 38 year old woman with a structurally normal heart presented with near syncope and had right ventricular outflow tract tachycardia. She was intolerant of antiarrhythmic medication and underwent low energy catheter ablation. Six non-arcing shocks of 25J were delivered to the right ventricular outflow tract. No further ventricular tachycardia occurred during a follow up of seven months without antiarrhythmic treatment.
Ventricular tachycardia of left bundle branch configuration and with an inferior axis in patients with structurally normal hearts is recognised as a clinical syndrome.' 3 It is usually brought on by stress and exercise and normally has a good prognosis.' Unlike most ventricular tachycardia, it can be suppressed by treatment with # blockers and calcium channel blockers. These features are consistent with a catecholamine sensitive focus arising from the right ventricular outflow tract. Experience with surgery and catheter ablation in this condition is limited.
We describe a patient with right ventricular outflow tract tachycardia and a structurally normal heart who was intolerant of antiarrhythmic medication and in whom low energy catheter ablation was successful.
Case report CLINICAL Low energy catheter ablation of right ventricular outflow tract tachycardia Discussion The ventricular tachycardia in this patient was uncharacteristic of that seen with ischaemic heart disease. It was brought on by exercise, stress, and isoprenaline infusion and extrasystoles were not recorded if the heart rate was below 100 beats/minute. It was abolished by metoprolol. This is all consistent with the tachycardia being very sensitive to catecholamine concentration. It was not inducible at electrophysiological study, even when isoprenaline was infused. The failure to induce the tachycardia with programmed electrical stimulation suggests that it was caused by automaticity or triggered activity not reentry.
The site of origin was localised by pacemapping to the right ventricular outflow tract. This is consistent with other reports.'26 We used an ablation system designed to reduce the delivered energy and barotrauma. 4 We believe that many of the serious side effects seen with conventional ablation are caused by the high energies used and the accompanying large pressure disturbances. These side effects have limited the use ofablation and a recent report of the world registry concluded that the use of ablation in the ventricle remains experimental.7 Measurements of voltage and current during the delivery of these six shocks showed that impedance remained constant and indicated that arcing had not taken place and therefore that no pressure disturbance had occurred.8 We suggest that it is particularly important to avoid barotrauma in thin walled structures such as the right ventricle and coronary sinus because of an increased risk of rupture. We believe that the use of this low energy ablation system will improve safety and reduce complications. The lack of rise in serum creatine kinase is also consistent with reduced myocardial damage. This is the first report of successful low energy catheter ablation of a catecholamine sensitive right ventricular outflow tract tachycardia. Reports of high energy catheter ablation in this condition are rare. Wilber et al described a patient in whom two conventional shocks of 200 J were delivered to a site in the outflow tract after an excellent pacemap but in whom ventricular tachycardia returned after several hours. This patient went on to have successful surgical ablation.6 At surgery the site of earliest endocardial breakthrough was 2 cm lateral to the site of the catheter ablation.
Hartzler described, in the first report ofcatheter ablation for ventricular tachycardia, a patient with successful ablation of right ventricular outflow tract tachycardia; this followed unsuccessful surgical endocardial resection.9 233 In this patient we delivered six low energy shocks. Our previous animal work (unpublished) showed that increasing numbers of low energy non-arcing shocks can produce lesions of similar size to those produced by shocks of much higher energies but without causing dangerous large pressure disturbances. Thus we believe that it is safer to deliver repeated non-arcing shocks than single much larger shocks. Unfortunately, failure to induce the tachycardia immediately after the ablation does not predict success in the next few hours or days because the cells essential to the tachycardia mechanism may be reversibly damaged and not necrotic. Thus at present there is no reliable end point at which ablation can be stopped. In this case ventricular tachycardia was not inducible; but after the first three shocks we saw single ventricular extrasystoles with the same configuration as the clinical ventricular tachycardia. Because we thought that insufficient damage had been produced we delivered three further shocks. After each of these we saw no further extrasystoles with the configuration of ventricular tachycardia.
The report by Wilber et al6 and our report are consistent with this syndrome being caused by a relatively localised abnormal area rather than a diffuse myocardial process. The localised nature of the substrate suggests that this syndrome may be suitable for treatment by catheter ablation in patients intolerant of medication.
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